[Hub]/) : Traits : Medication: Metformin :

chr15:89,680,384-91,135,411

Best TWAS P=3.27e-08 · Best GWAS P=5.15e-08 conditioned to 1

Associated models

# Study Tissue Gene h2 eQTL R2 model # weights model R2 model R2 P eQTL GWAS Z TWAS Z TWAS P Top SNP corr PP3 PP4 joint
1 GTEx Cells Transformed fibroblasts AP3S2 0.22 0.16 lasso 5 0.18 4.1e-13 5.3 5.2 1.6e-07 0.98 0.01 0.99 FALSE
2 GTEx Esophagus Mucosa AP3S2 0.19 0.16 lasso 1 0.15 4.0e-10 5.2 5.2 2.4e-07 0.96 0.00 0.99 FALSE
3 NTR Blood AP3S2 0.17 0.11 enet 26 0.14 2.7e-43 4.9 5.2 2.0e-07 0.90 0.01 0.99 FALSE
4 The Cancer Genome Atlas Bladder Urothelial Carcinoma AP3S2 0.19 0.27 lasso 4 0.24 2.0e-20 5.2 5.2 2.6e-07 0.94 0.01 0.99 FALSE
5 The Cancer Genome Atlas Breast Invasive Carcinoma AP3S2 0.13 0.19 lasso 5 0.20 5.3e-40 5.3 5.2 1.6e-07 0.97 0.00 1.00 FALSE
6 The Cancer Genome Atlas Cervical Squamous Cell Carcinoma AP3S2 0.23 0.27 lasso 1 0.26 3.8e-13 5.4 5.4 5.1e-08 1.00 0.00 1.00 FALSE
7 The Cancer Genome Atlas Colon Adenocarcinoma AP3S2 0.18 0.18 lasso 4 0.17 5.2e-10 5.4 5.5 3.3e-08 0.97 0.00 1.00 TRUE
8 The Cancer Genome Atlas Esophageal Carcinoma AP3S2 0.22 0.15 lasso 2 0.13 6.2e-05 5.4 5.4 5.3e-08 1.00 0.00 0.99 FALSE
9 The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma AP3S2 0.15 0.24 enet 14 0.27 6.3e-30 5.4 5.2 1.5e-07 0.97 0.00 1.00 FALSE
10 The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma C15orf38 0.02 0.03 lasso 1 0.02 1.9e-03 5.3 -5.3 1.3e-07 -0.98 0.00 0.94 FALSE
11 The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma AP3S2 0.27 0.38 lasso 4 0.39 3.1e-47 4.9 5.2 2.6e-07 0.98 0.02 0.98 FALSE
12 The Cancer Genome Atlas Brain Lower Grade Glioma AP3S2 0.23 0.27 lasso 6 0.30 3.2e-34 5.3 5.3 8.8e-08 0.97 0.01 0.99 FALSE
13 The Cancer Genome Atlas Liver Hepatocellular Carcinoma AP3S2 0.27 0.22 lasso 5 0.23 3.0e-11 5.2 5.2 2.0e-07 0.97 0.00 1.00 FALSE
14 The Cancer Genome Atlas Lung Adenocarcinoma AP3S2 0.22 0.38 lasso 4 0.39 2.3e-48 5.0 5.2 2.3e-07 0.97 0.02 0.98 FALSE
15 The Cancer Genome Atlas Lung Squamous Cell Carcinoma AP3S2 0.22 0.26 enet 18 0.30 1.6e-34 5.3 5.3 1.5e-07 0.95 0.01 0.99 FALSE
16 The Cancer Genome Atlas Pancreatic Adenocarcinoma AP3S2 0.44 0.37 lasso 3 0.39 2.2e-17 4.9 5.1 2.7e-07 0.97 0.01 0.99 FALSE
17 The Cancer Genome Atlas Prostate Adenocarcinoma AP3S2 0.44 0.54 enet 13 0.55 3.3e-68 5.3 5.2 2.1e-07 0.98 0.00 1.00 FALSE
18 The Cancer Genome Atlas Rectum Adenocarcinoma AP3S2 0.18 0.19 lasso 5 0.15 2.1e-04 4.9 5.2 1.9e-07 0.98 0.01 0.91 FALSE
19 The Cancer Genome Atlas Soft Tissue Sarcoma AP3S2 0.14 0.18 enet 5 0.16 1.2e-09 5.2 5.3 1.2e-07 0.98 0.00 1.00 FALSE
20 The Cancer Genome Atlas Stomach Adenocarcinoma AP3S2 0.13 0.16 lasso 2 0.17 2.6e-12 5.2 5.2 1.6e-07 0.96 0.01 0.99 FALSE
21 The Cancer Genome Atlas Thyroid Carcinoma AP3S2 0.30 0.45 lasso 7 0.44 7.0e-47 4.9 5.1 2.9e-07 0.96 0.03 0.97 FALSE
22 The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma AP3S2 0.26 0.25 lasso 4 0.25 1.4e-07 5.4 5.3 1.3e-07 0.99 0.01 0.99 FALSE